Episode #1
体育强国7万亿目标，大多数人只看到了前四条
Aug 31, 20263 min
国家体育总局近日发布《体育强国建设“十五五”规划》，这是首个以“体育强国”为主题的国家级专项规划。体育强国不仅是金牌和赛事，更是楼下能否踢球、下班后能否跑步的生活细节，归根结底，体育强国的刻度是普通人自然运动的瞬间。
Loading…
Loading…
华大基因专业团队倾情打造，基因科普娓娓道来！
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
40%
Guest openness
Selective
Sign up to generate a grounded pitch for 天方烨谈.
Signup to Generate a Pitch天方烨谈 is a science podcast hosted by 基因频道, with 1,000 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
基因频道 hosts 天方烨谈, a science show with 1,000 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #1
国家体育总局近日发布《体育强国建设“十五五”规划》，这是首个以“体育强国”为主题的国家级专项规划。体育强国不仅是金牌和赛事，更是楼下能否踢球、下班后能否跑步的生活细节，归根结底，体育强国的刻度是普通人自然运动的瞬间。
Episode #1
当我们谈论压力时，往往聚焦于情绪的起伏，却很少察觉它在细胞层面掀起的风暴。压力不仅侵蚀情绪，更在细胞层面加速衰老——端粒缩短揭示慢性压力如何穿透DNA。心态决定端粒命运，学会转化压力才能守护生命时钟。
Episode #2
2026年5月，在芝加哥举行的美国临床肿瘤学会（ASCO）年会上，当胰腺癌新药的临床数据公布时，全场起立鼓掌42秒——这款革命性口服药终于攻克了“不可成药”的RAS靶点，将患者生存期延长近一倍。如今，Revolution Medicines正式宣布，其口服泛RAS抑制剂Rasonque（daraxonrasib）已获得美国FDA批准，用于既往接受过至少一种全身治疗、或不适合接受多药联合全身治疗的成人转移性胰腺导管腺癌（PDAC）患者。这是首个获批用于胰腺癌治疗的广谱RAS靶向口服药物，也意味着RAS靶向治疗在胰腺癌领域进一步向前推进。
Episode #1
今年8月24日，葛兰素史克（GSK）宣布，其研发的反义寡核苷酸药物贝普若韦生（Bepirovirsen，商品名Hibsago） 正式获得日本厚生劳动省批准上市。这是全球首款获批用于慢性乙型肝炎“功能性治愈”的药物。2.4亿慢性乙肝感染者的等待，终于有了答案。
Episode #1
台湾木蠊用最硬核的仪式表达爱意：互啃翅膀—达成它们的“婚前协议”，从此成为专一伴侣，共同筑巢育雏。科学家发现，这个残忍仪式让它们的攻击性提升10倍，配合更默契，而失去翅膀反而让它们在腐木隧道中行动更自由。
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
